[IgM-lambda multiple myeloma presenting with systemic amyloidosis]

Rinsho Ketsueki. 2009 Dec;50(12):1711-4.
[Article in Japanese]

Abstract

A 59-year-old man was referred to our hospital due to nephrotic syndrome with IgM paraproteinemia. Physical examination demonstrated marked hepatomegaly and anasarca. Serum M-protein was 0.94 g/dl and urinary analysis detected the presence of Bence Jones protein. Bone marrow plasma cell count was 11.2%. Histological examination demonstrated AL-type amyloid deposition in the liver, kidneys, bone marrow, stomach and rectum. These findings led to a diagnosis of IgM multiple myeloma with systemic amyloidosis. Although there was no apparent response to 2 courses of vincristine, doxorubicin and dexamethasone (VAD) regimen, subsequent treatment with bortezomib in combination with dexamethasone resulted in a rapid reduction in M protein to 0.49 g/dl, approximately half the pre-treatment level.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Amyloidosis / diagnosis
  • Amyloidosis / etiology*
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Boronic Acids / administration & dosage
  • Bortezomib
  • Dexamethasone / administration & dosage
  • Doxorubicin / administration & dosage
  • Fatal Outcome
  • Humans
  • Immunoglobulin M* / blood
  • Male
  • Middle Aged
  • Multiple Myeloma / complications*
  • Multiple Myeloma / diagnosis
  • Multiple Myeloma / drug therapy
  • Paraproteinemias / blood
  • Paraproteinemias / complications
  • Pyrazines / administration & dosage
  • Vincristine / administration & dosage

Substances

  • Boronic Acids
  • Immunoglobulin M
  • Pyrazines
  • Vincristine
  • Bortezomib
  • Dexamethasone
  • Doxorubicin

Supplementary concepts

  • VAD protocol